I understand your point about no risk and while I disagree with...

I understand your point about no risk and while I disagree with you, I think your opinion is fair. However, I don't think it's fair to say that people who would say no to $50 dollars have rocks in their head, people who say no to that kind of money, they've usually done their research and have a great understanding of both the drug and the company, and the market potential for both. They don't have 'rocks' in their head, but when you're sitting on something that market doesn't quite understand as of yet, to an outsider it is a no brainer, but to those who are confident in the drug and the management, they'll know they missed an opportunity of a lifetime.